These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20799519)

  • 41. Detection of CYP2D6 polymorphisms *9, *10, and *41 using ARMS-PCR and their allelic frequencies in 400 psychiatric patients.
    Hinrichs JW; Smallegoor WD; van Baalen-Benedek EH; Welker C; van der Weide J
    Clin Chem Lab Med; 2007; 45(4):555-7. PubMed ID: 17439339
    [No Abstract]   [Full Text] [Related]  

  • 42. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
    Fang P; Zheng X; He J; Ge H; Tang P; Cai J; Hu G
    Drug Des Devel Ther; 2017; 11():1283-1290. PubMed ID: 28461741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.
    Vandel P; Talon JM; Haffen E; Sechter D
    Curr Pharm Des; 2007; 13(2):241-50. PubMed ID: 17269931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP2D6*4 allele and breast cancer risk: is there any association?
    Fernández-Santander A; del Saz Sánchez M; Tejerina Gómez A; Bandrés Moya F
    Clin Transl Oncol; 2012 Feb; 14(2):157-9. PubMed ID: 22301406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy.
    Campbell NL; Skaar TC; Perkins AJ; Gao S; Li L; Khan BA; Boustani MA
    Clin Interv Aging; 2015; 10():269-75. PubMed ID: 25609939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.
    de Leon J; Barnhill J; Rogers T; Boyle J; Chou WH; Wedlund PJ
    Am J Psychiatry; 1998 Sep; 155(9):1278-80. PubMed ID: 9734555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CYP2D6 variability in populations from Venezuela.
    Moreno N; Flores-Angulo C; Villegas C; Mora Y
    Drug Metab Pers Ther; 2016 Dec; 31(4):181-189. PubMed ID: 27875317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
    Hu X; Lan T; Dai D; Xu RA; Yuan L; Zhou Q; Li Y; Cai J; Hu G
    Drug Metab Dispos; 2016 Nov; 44(11):1828-1831. PubMed ID: 27538917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in fatigue severity in a sample of adult cancer patients.
    Gonzalez VJ; Tofthagen CS; Chen X; Pedro E; Saligan LN
    J Clin Nurs; 2018 Sep; 27(17-18):3345-3354. PubMed ID: 28382641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interethnic relationships of CYP2D6 variants in native and Mestizo populations sharing the same ecosystem.
    Perez-Paramo YX; Hernandez-Cabrera F; Dorado P; Llerena A; Muñoz-Jimenez S; Ortiz-Lopez R; Rojas-Martinez A
    Pharmacogenomics; 2015; 16(7):703-12. PubMed ID: 25941923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The genomic landscape of
    Sivadas A; Rathore S; Sahana S; Jolly B; Bhoyar RC; Jain A; Sharma D; Imran M; Senthilvel V; Divakar MK; Mishra A; Sivasubbu S; Scaria V
    Pharmacogenomics; 2024 Feb; 25(3):147-160. PubMed ID: 38426301
    [No Abstract]   [Full Text] [Related]  

  • 52. Experience of nervousness and anxiety disorders in Puerto Rican women: psychiatric and ethnopsychological perspectives.
    Koss-Chioino JD
    Health Care Women Int; 1989; 10(2-3):245-72. PubMed ID: 2768094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Important considerations for recruiting women to cancer genetics studies in Puerto Rico.
    August EM; Quinn GP; Perales R; Closser Z; Dutil J; Puig M; Vadaparampil ST
    J Cancer Educ; 2012 Mar; 27(1):105-11. PubMed ID: 21866412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional characterization of CYP2D6 novel allelic variants identified in the Chinese Han population.
    Xu Q; Wu Z; Yang L; Zhang X; Gai Z; Chen L; He L; Qin S
    Pharmacogenomics; 2016; 17(2):119-9. PubMed ID: 26652007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CYP2D6 ultra-rapid metabolizer phenotype not associated with attempted suicide in a large sample of psychiatric inpatients.
    Stephens DB; de Leon J
    Pharmacogenomics; 2016 Aug; 17(12):1295-304. PubMed ID: 27463022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Health related Quality of Life of Puerto Ricans during Cancer Treatments; A Pilot Study.
    Gonzalez VJ; McMillan S; Pedro E; Tirado-Gomez M; Saligan LN
    P R Health Sci J; 2018 Mar; 37(1):46-51. PubMed ID: 29547684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of CYP2D6 genetic variation on adverse events with propafenone in the pediatric and young adult population.
    Sunthankar SD; Kannankeril PJ; Gaedigk A; Radbill AE; Fish FA; Van Driest SL
    Clin Transl Sci; 2022 Jul; 15(7):1787-1795. PubMed ID: 35514162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The potential impact of CYP2D6 (*2/*4/*10) gene variants among Egyptian epileptic children: A preliminary study.
    Elsaid AM; Zahran RF; Elmetwaly SM; Wahba Y; Megahed H; Elshazli RM
    Gene; 2022 Jul; 832():146585. PubMed ID: 35597526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess.
    von Ahsen N; Tzvetkov M; Karunajeewa HA; Gomorrai S; Ura A; Brockmöller J; Davis TM; Mueller I; Ilett KF; Oellerich M
    Int J Mol Epidemiol Genet; 2010 Aug; 1(4):310-9. PubMed ID: 21532842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physiogenomic analysis of the Puerto Rican population.
    Ruaño G; Duconge J; Windemuth A; Cadilla CL; Kocherla M; Villagra D; Renta J; Holford T; Santiago-Borrero PJ
    Pharmacogenomics; 2009 Apr; 10(4):565-77. PubMed ID: 19374515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.